Executive Summary
SAIC was awarded an $806M obligated (potential $1.26B) DoS IT engineering contract via full competition, representing a major revenue stream with $377M already outlayed. High subcontracting ($946M across 398 recipients) underscores execution scale but introduces dependencies. Contract ends May 2025 without extension signals, prioritizing option exercises and follow-on potential for sustained growth.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal IT & Cybersecurity Contracts digest from February 28, 2026.
Investment Signals (1)
- SAIC Major DoS IT Win (HIGH)▲
Full competition award of $806M obligation (up to $1.26B options) for IT engineering services, with $377M outlayed, boosts revenue visibility.
Risk Flags (2)
- Execution [HIGH RISK]▼
Performance ends 2025-05-08 with no extension indicated, risking revenue cliff post-$806M obligation.
- Execution [MEDIUM RISK]▼
$946M subawards across 398 recipients create supply chain dependencies.
Opportunities (2)
- ◆
Unexercised options could lift value from $806M to $1.26B.
- ◆
Lead integrator role positions for DoS follow-on IT work.
Sector Themes (2)
- ◆
Full/open competition for large-scale IT engineering at DoS highlights sustained government spending.
- ◆
$946M subawards in single contract indicate broad ecosystem involvement.
Watch List (2)
- 👁
{"entity"=>"SAIC DoS Contract", "reason"=>"Nearing end with $453M unexercised options and high subawards.", "trigger"=>"Option calls or extension notices by Q1 2025"}
- 👁
{"entity"=>"DoS IT Recompetes", "reason"=>"Lead role positions SAIC for follow-ons amid $1.26B precedent.", "trigger"=>"RFPs post-2025-05-08"}
Get daily alerts with 1 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal IT & Cybersecurity Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
US Pre-Market SEC Filings Roundup — May 26, 2026
US Pre-Market SEC Filings Roundup
May 26, 2026
Biotech Small-Cap Approvals — May 26, 2026
Biotech Small-Cap Approvals
May 26, 2026
Big Pharma Approvals — May 26, 2026
Big Pharma Approvals